Details of Disease
General Information of Disease (ID: DIS3L6GZ)
| Disease Name | Renal-hepatic-pancreatic dysplasia | |||||
|---|---|---|---|---|---|---|
| Synonyms | Renohepaticopancreatic dysplasia; Ivemark's syndrome; Ivemark II syndrome | |||||
| Definition |
A rare, genetic, developmental defect during embryogenesis syndrome characterized by the triad of pancreatic fibrosis (and cysts, with a reduction of parenchymal tissue), renal dysplasia (with peripheral cortical cysts, primitive collecting ducts, glomerular cysts and metaplastic cartilage) and hepatic dysgenesis (enlarged portal areas containing numerous elongated binary profiles with a tendancy to perilobular fibrosis). Situs abnormalities, skeletal anomalies and anencephaly have also been associated. Patients that survive the neonatal period present renal insufficiency, chronic jaundice and insulin-dependant diabetes.
|
|||||
| Disease Hierarchy | ||||||
| Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
This Disease Is Related to 2 DTT Molecule(s)
|
||||||||||||||||||||||||||||||
|
This Disease Is Related to 2 DOT Molecule(s)
|
||||||||||||||||||||||||||||||
References
